Novamen SAS

Novamen SAS is a company in Lyon, France that has taken part in 13 EU-funded projects since 2008, receiving €1.1M in EU funding.

EU funding received€1.1M
EU projects13
As coordinator0
Running now0
First EU project2008
Latest project2013
CountryFrance
EU registration (PIC)995663679
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Novamen SAS's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€1.1M · 13 projects

Projects

13 EU-funded projects, newest first. Each links to the official record.

  • RESOLVEPartner

    A systems biology approach to RESOLVE the molecular pathology of two hallmarks of patients with metabolic syndrome and its co-morbidities; hypertriglyceridemia and low HDL-cholesterol

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

  • DESSCIPHERPartner

    To decipher the optimal management of systemic sclerosis

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

  • SEABIOTECHPartner

    From sea-bed to test-bed: harvesting the potential of marine microbes for industrial biotechnology

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

  • DARTRIXPartner

    DARPin Targeted Magnetic Hyperthermic Therapy for Glioblastoma

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

  • DO-HEALTHPartner

    VitaminD3-Omega3-Home Exercise- HeALTHy Ageing and Longevity Trial

    FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗

  • IMAGINTPartner

    HER Imaging and Molecular Interaction Mapping in Breast Cancer

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €193ktheir share
  • INOMANS²HIPPartner

    INOvative Energy MANagement System for Cargo SHIP

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

  • MODHEPPartner

    Systems biology of liver cancer: an integrative genomic-epigenomic approach

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

    €167ktheir share
  • CUT'HIVACPartner

    Cutaneous and Mucosal HIV Vaccination

    FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗

    €368ktheir share
  • BIO-NMDPartner

    Identifying and validating pre-clinical biomarkers for diagnostics and therapeutics of Neuromuscular Disorders

    FP7 (2007 to 2013) · 2009–2012 · Project on CORDIS ↗

    €162ktheir share
  • PERSISTPartner

    Persisting Transgenesis

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

  • SPIDIAPartner

    Standardisation and improvement of generic pre-analytical tools and procedures for in vitro diagnostics

    FP7 (2007 to 2013) · 2008–2013 · Project on CORDIS ↗

    €238ktheir share
  • SYBILLAPartner

    Systems Biology of T-cell Activation in Health and Disease

    FP7 (2007 to 2013) · 2008–2013 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • HIV
  • RNA
  • alzheimer
  • autoimmune diseases
  • breast cancer
  • cardiovascular diseases
  • cell signaling
  • computational intelligence
  • databases
  • diabetes
  • drug discovery
  • ecosystems
  • fisheries

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime